Fatemeh Zarimeidani: Advancing Care for PCOS-Related Infertility
Fatemeh Zarimeidani shared a post on LinkedIn:
“Advancing Care for PCOS‑related Infertility
Polycystic ovarian syndrome (PCOS) is the most common cause of anovulatory infertility.
Letrozole (LE) has emerged as the first‑line ovulation induction therapy for PCOS, offering higher ovulation and live birth rates with a lower risk of multiple gestations compared to clomiphene citrate.
Our team recently conducted a single‑center, parallel randomized clinical trial comparing two LE regimens in treatment‑resistant PCOS patients:
- 7‑day treatment (Group A)
- 10‑day treatment (Group B)
Primary outcomes ovulation rates and follicle measurements
Secondary outcomes pregnancy rates and safety profiles
Key takeaway:
Both regimens were safe and effective, with no significant difference in ovulation or pregnancy rates, though we observed a trend worth exploring further.
Why it matters:
This is the first study to directly compare 7‑day vs. 10‑day Letrozole protocols. While larger trials are needed to confirm the benefits of extended therapy, these findings can help clinicians refine treatment plans for anovulatory PCOS patients who are resistant to standard protocols.
As this reflects my first experience working on clinical trial articles, I would love to hear your kind thoughts on the methodology and how you think it could be enhanced.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Mar 15, 2026, 15:26Watching Life Begin: Scientists Track Embryo Implantation in Real Time! – Science Magazine
-
Mar 15, 2026, 15:03Reem Abu-Rustum Spotlights Fetal Situs in New ISUOG Quiz – ISUOG
-
Mar 15, 2026, 14:59Tamoxifen or Letrozole for Fertility Preservation in Breast Cancer! – Fertility and Sterility
-
Mar 15, 2026, 14:55Scientific Speed Dating Expands to Two Days at ESHRE 2026 – ESHRE
-
Mar 15, 2026, 14:32ESHRE Calls for ART Clinicians and Lab Experts for PGT Working Groups – ESHRE
-
Mar 15, 2026, 14:26How Autoimmune Diseases Can Affect Fertility – Harley Street Fertility Centre Kenya
-
Mar 15, 2026, 14:17Study Highlights the Role of Oxygen Delivery in Tissue Regeneration – BHOC
-
Mar 15, 2026, 14:10Highlights from MEFS 2025 Advancing Reproductive Medicine – MEFS
-
Mar 15, 2026, 08:18MHR Calls for Papers on Organoids, Assembloids and Emerging 3D Reproductive Models – ESHRE